Complete revascularization improves blood pressure control and clinical prognosis in patients with acute myocardial infarction by reducing oxidative stress

完全血运重建可通过降低氧化应激,改善急性心肌梗死患者的血压控制和临床预后。

阅读:4

Abstract

OBJECTIVE: To investigate the effects of complete revascularization on oxidative stress, blood pressure control, and prognosis in patients with acute myocardial infarction (AMI). METHODS: Clinical data from 80 AMI patients were retrospectively analyzed. Based on the SYNTAX Revascularization Index (SRI), patients were classified into the complete revascularization group (SRI=100%, n=31), partial revascularization group (SRI 50-99%, n=27), and low revascularization group (SRI<50%, n=22). Postoperative oxidative stress markers (malondialdehyde, MDA; angiotensin converting enzyme, ACE; and superoxide dismutase, SOD), myocardial injury marker (cardiac Troponin I, cTnI), and ambulatory blood pressure parameters were compared among groups. Their correlations were analyzed, and the predictive value of SRI for major adverse cardiovascular events (MACE) was evaluated. RESULTS: One month after surgery, the complete revascularization group exhibited significantly lower MDA than the partial and low revascularization groups, higher SOD, and lower ACE and cTnI levels (all P<0.001). Six months postoperatively, the complete revascularization group showed improvements in 24 h SBP, 24 h SBP-SD and nocturnal blood pressure decline rate (all P<0.01). The incidence of MACE was significantly lower in the complete revascularization group (6.45% vs. 36.73%, P=0.002). Logistic regression showed that SRI was an independent protective factor for MACE (OR=0.119, 95% CI: 0.025-0.557, P=0.007). ROC curve analysis indicated its predictive value for MACE with an AUC of 0.835 and an optimal cut-off value of 69.360%. CONCLUSION: Complete revascularization improves blood pressure stability and reduces MACE risk in AMI patients by alleviating oxidative stress. Achieving an SRI above 69.360% can be considered a clinical target.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。